For example, most of the familial neuroblastoma harboured mutations in genes ALK16, 17 and PHOX2B. 18A clinical trial of an inhibitor of ALK was launched soon after the initial discovery of ALK mutations. The gene discussed is ALK; the disease is neuroblastoma.